Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Orange

Showing results (161-170 of 357) with videos related to

Pageof 36
Sort By:
Journal of Clinical Immunology|May 11, 2010
Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiencyJohn B Hagan, Mary B Fasano, Sheldon Spector, et al.
The Journal of Experimental Medicine|March 1, 1995
Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoidsJ S Orange, T P Salazar-Mather, S M Opal, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 14, 2025
Reported Demographics of Primary Immunodeficiency Diseases in the United StatesLavinia Ferrante di Ruffano, Emma Carr, Mary Edwards, et al.
The Journal of Infectious Diseases|July 9, 2016
Schistosome Soluble Egg Antigen Decreases Mycobacterium tuberculosis-Specific CD4+ T-Cell Effector Function With Concomitant Arrest of Macrophage Phago-Lysosome MaturationAndrew R DiNardo, Emily M Mace, Kelsey Lesteberg, et al.
Advances in Experimental Medicine and Biology|May 11, 2021
Coronavirus: Pure Infectious Disease or Genetic PredispositionFarzaneh Darbeheshti, Hassan Abolhassani, Mohammad Bashashati, et al.
Journal of Research in Pharmacy Practice|August 2, 2019
Outcome Evaluation of a Subcutaneous Immunoglobulin Clinical Management ProgramJulia Zhu, Gretchen Ayer, Heather S Kirkham, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 4, 2018
Clinical and economic outcomes of a "high-touch" clinical management program for intravenous immunoglobulin therapyJulia Zhu, Heather S Kirkham, Gretchen Ayer, et al.
Blood|February 23, 2013
The adaptor molecule SAP plays essential roles during invariant NKT cell cytotoxicity and lytic synapse formationRupali Das, Hamid Bassiri, Peng Guan, et al.
The Journal of Cell Biology|December 2, 2016
NK cells converge lytic granules to promote cytotoxicity and prevent bystander killingHsiang-Ting Hsu, Emily M Mace, Alexandre F Carisey, et al.
Immunology Letters|March 27, 2012
Tumorigenic adenovirus 12 cells evade NK cell lysis by reducing the expression of NKG2D ligandsChrista Y Heyward, Rajen Patel, Emily M Mace, et al.
Pageof 36

Showing results (161-170 of 357) with videos related to

Sort By:
Pageof 36
Journal of Clinical Immunology|May 11, 2010
Efficacy and safety of a new 20% immunoglobulin preparation for subcutaneous administration, IgPro20, in patients with primary immunodeficiencyJohn B Hagan, Mary B Fasano, Sheldon Spector, et al.
The Journal of Experimental Medicine|March 1, 1995
Mechanism of interleukin 12-mediated toxicities during experimental viral infections: role of tumor necrosis factor and glucocorticoidsJ S Orange, T P Salazar-Mather, S M Opal, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 14, 2025
Reported Demographics of Primary Immunodeficiency Diseases in the United StatesLavinia Ferrante di Ruffano, Emma Carr, Mary Edwards, et al.
The Journal of Infectious Diseases|July 9, 2016
Schistosome Soluble Egg Antigen Decreases Mycobacterium tuberculosis-Specific CD4+ T-Cell Effector Function With Concomitant Arrest of Macrophage Phago-Lysosome MaturationAndrew R DiNardo, Emily M Mace, Kelsey Lesteberg, et al.
Advances in Experimental Medicine and Biology|May 11, 2021
Coronavirus: Pure Infectious Disease or Genetic PredispositionFarzaneh Darbeheshti, Hassan Abolhassani, Mohammad Bashashati, et al.
Journal of Research in Pharmacy Practice|August 2, 2019
Outcome Evaluation of a Subcutaneous Immunoglobulin Clinical Management ProgramJulia Zhu, Gretchen Ayer, Heather S Kirkham, et al.
Clinicoeconomics and Outcomes Research : CEOR|January 4, 2018
Clinical and economic outcomes of a "high-touch" clinical management program for intravenous immunoglobulin therapyJulia Zhu, Heather S Kirkham, Gretchen Ayer, et al.
Blood|February 23, 2013
The adaptor molecule SAP plays essential roles during invariant NKT cell cytotoxicity and lytic synapse formationRupali Das, Hamid Bassiri, Peng Guan, et al.
The Journal of Cell Biology|December 2, 2016
NK cells converge lytic granules to promote cytotoxicity and prevent bystander killingHsiang-Ting Hsu, Emily M Mace, Alexandre F Carisey, et al.
Immunology Letters|March 27, 2012
Tumorigenic adenovirus 12 cells evade NK cell lysis by reducing the expression of NKG2D ligandsChrista Y Heyward, Rajen Patel, Emily M Mace, et al.
Pageof 36